0.0015
0.0000
(0.00%)
May 22 - Close
OTCMKTS
data delayed by 15 mins -
Disclaimer
Currency in USD
| Range | - |
| 52 week | 0.00 - 0.01 |
| Open | - |
| Vol / Avg. | 0.00/2,400.00 |
| Mkt cap | 46,084.00 |
| P/E | - |
| Div/yield | - |
| EPS | -0.25 |
| Shares | 30.72M |
| Beta | -4.35 |
| Inst. own | 9% |
Key stats and ratios
| Q3 (Sep '08) | 2007 | |
| Net profit margin | -5554.41% | -6719.15% |
| Operating margin | -5706.98% | -6992.55% |
| EBITD margin | - | -6423.40% |
| Return on average assets | -445.17% | -157.15% |
| Return on average equity | - | - |
| Employees | 18 | - |
| Carbon Disclosure Rating | - | - |
Address
Suite 504, 4100 Yonge St
TORONTO, ON M2P 2A9
Canada
+1-416-2269949 (Phone)
+1-647-4391329 (Fax)
TORONTO, ON M2P 2A9
Canada
+1-416-2269949 (Phone)
+1-647-4391329 (Fax)
Website links
External links
Discussion Group - Google Finance
Advertisement
Description
PreMD Inc. is a medical device company. The Company is engaged in the development and sale of non-invasive tests that detect early stage cardiovascular diseases and cancers. The Company�s products include PREVU Skin Sterol Test, ColorectAlert, LungAlert and Breast Cancer Test. The company's PREVU Skin Sterol Test is a simple, non-invasive skin cholesterol test that is used in the determination of the risk assessment of coronary artery disease (CAD). The Company�s ColorectAlert is a screening test for colorectal cancer. LungAler is a screening test for colorectal cancer. Breast Cancer Test is a screening test for breast cancer. In addition to this, the Company has many products in its pipeline, which are in various stages of development. The products include the Color Measurement product, Other Cancers product, Colopath and the Genomics products.